Business Context and Reporting Period
This Form 8-K Current Report is filed by iBio, Inc. for the reporting period ending May 31, 2018. The filing addresses a corporate action taken to regain compliance with NYSE American listing standards regarding minimum share price requirements.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The primary quantitative data relates to capital structure adjustments:
- Pre-split Outstanding Shares: Approximately 115.9 million.
- Post-split Outstanding Shares: Approximately 11.6 million.
- Reverse Split Ratio: One-for-ten (1:10).
Material Changes
The material change reported is the Board of Directors' approval of a 1:10 reverse stock split. This action was necessitated by a notice received on January 4, 2018, from the NYSE American indicating that the Company's continued listing was predicated on effecting a reverse split or demonstrating sustained share price improvement by July 5, 2018. Stockholders approved the authority for a split between 1:2 and 1:10 at a special meeting on April 23, 2018.
Outlook, Risks, and Unusual Items
Implementation Timeline: The reverse split is expected to become effective on June 8, 2018, upon the filing of a Certificate of Amendment. Trading on a reverse split-adjusted basis is anticipated to begin on June 11, 2018.
Fractional Shares: No fractional shares will be issued. Stockholders entitled to fractional shares will receive a cash payment in lieu thereof.
Risk Context: The primary risk addressed is the potential delisting from the NYSE American due to low share price, which this action aims to mitigate.
Investor Verification Checklist
- Verify the effective date of the Certificate of Amendment to confirm the June 8, 2018 timeline.
- Confirm the exact trading start date for the reverse split-adjusted shares (expected June 11, 2018).
- Review instructions from the transfer agent, Continental Stock Transfer & Trust, regarding the exchange process and cash payments for fractional shares.
- Monitor the Company's share price post-split to ensure sustained compliance with NYSE American listing standards.